To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

Knome appoints Martin Tolar as chief executive

By Chris Reidy

 |  Globe Staff  

  January 09, 2012

Knome Inc., a Cambridge life sciences company specializing in human genome interpretation, has appointed Martin Tolar, M.D., as its chief executive. Knome supports researchers with the informatics and software tools used to investigate the genetic basis of human disease and drug response. Before joining Knome, Tolar was chief executive of Normoxys Inc. Jorge Conde, Knome’s founding CEO, will become chief strategy officer and continue to serve on its board of directors.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help